A deficiency of IDS activity results in systemic accumulation of GAGs, leading to a rare metabolic disease, mucopolysaccharidosis type II (MPS II, OMIM 309900), which is also known as Hunter syndrome [1]. This evidence concerns the gene IDS and mucopolysaccharidosis type 2.